Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 388 entries
Sorted by: Best Match Show Resources per page
What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold.

Cureus

MacEwan MR, MacEwan S, Kovacs TR, Batts J.
PMID: 29209583
Cureus. 2017 Oct 02;9(10):e1736. doi: 10.7759/cureus.1736.

Wound matrix materials are used to improve the regeneration of dermal and epidermal layers in both acute and chronic wounds. Contemporary wound matrices are primarily composed of biologic materials such as processed xenogeneic and allogeneic tissues. Unfortunately, existing biologic...

Cite
MacEwan MR, MacEwan S, Kovacs TR, et al. What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold. Cureus. 2017;9(10):e1736doi: 10.7759/cureus.1736.
MacEwan, M. R., MacEwan, S., Kovacs, T. R., & Batts, J. (2017). What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold. Cureus, 9(10), e1736. https://doi.org/10.7759/cureus.1736
MacEwan, Matthew R, et al. "What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold." Cureus vol. 9,10 (2017): e1736. doi: https://doi.org/10.7759/cureus.1736
MacEwan MR, MacEwan S, Kovacs TR, Batts J. What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold. Cureus. 2017 Oct 02;9(10):e1736. doi: 10.7759/cureus.1736. PMID: 29209583; PMCID: PMC5711514.
Copy Download .nbib Format: NLM
Less is more.

The Journal of thoracic and cardiovascular surgery

Tong BC.
PMID: 27986253
J Thorac Cardiovasc Surg. 2017 Jan;153(1):196. doi: 10.1016/j.jtcvs.2016.10.020. Epub 2016 Oct 24.

No abstract available.

Cite
Tong BC. Less is more. J Thorac Cardiovasc Surg. 2016;153(1):196doi: 10.1016/j.jtcvs.2016.10.020.
Tong, B. C. (2017). Less is more. The Journal of thoracic and cardiovascular surgery, 153(1), 196. https://doi.org/10.1016/j.jtcvs.2016.10.020
Tong, Betty C. "Less is more." The Journal of thoracic and cardiovascular surgery vol. 153,1 (2017): 196. doi: https://doi.org/10.1016/j.jtcvs.2016.10.020
Tong BC. Less is more. J Thorac Cardiovasc Surg. 2017 Jan;153(1):196. doi: 10.1016/j.jtcvs.2016.10.020. Epub 2016 Oct 24. PMID: 27986253.
Copy Download .nbib Format: NLM
Clozapine Intoxication Mimicking Acute Stroke.

Clinical practice and cases in emergency medicine

Lebin JA, Villarreal JD, Chen BC, Hall MK.
PMID: 29849223
Clin Pract Cases Emerg Med. 2018 Apr 05;2(2):155-157. doi: 10.5811/cpcem.2018.1.36734. eCollection 2018 May.

Clozapine is an atypical antipsychotic drug prescribed for treatment-resistant schizophrenia. The risk of adverse hematologic, cardiovascular, and neurologic effects has tempered its use, and reports of overdoses remain rare. We report a case of accidental acute clozapine intoxication in...

Cite
Lebin JA, Villarreal JD, Chen BC, et al. Clozapine Intoxication Mimicking Acute Stroke. Clin Pract Cases Emerg Med. 2018;2(2):155-157doi: 10.5811/cpcem.2018.1.36734.
Lebin, J. A., Villarreal, J. D., Chen, B. C., & Hall, M. K. (2018). Clozapine Intoxication Mimicking Acute Stroke. Clinical practice and cases in emergency medicine, 2(2), 155-157. https://doi.org/10.5811/cpcem.2018.1.36734
Lebin, Jacob A, et al. "Clozapine Intoxication Mimicking Acute Stroke." Clinical practice and cases in emergency medicine vol. 2,2 (2018): 155-157. doi: https://doi.org/10.5811/cpcem.2018.1.36734
Lebin JA, Villarreal JD, Chen BC, Hall MK. Clozapine Intoxication Mimicking Acute Stroke. Clin Pract Cases Emerg Med. 2018 Apr 05;2(2):155-157. doi: 10.5811/cpcem.2018.1.36734. eCollection 2018 May. PMID: 29849223; PMCID: PMC5965117.
Copy Download .nbib Format: NLM
Risk Assessment or Assessment of Risk? Developing an Evidence-Based Approach for Primary Producers of Leafy Vegetables To Assess and Manage Microbial Risks.

Journal of food protection

Monaghan JM, Augustin JC, Bassett J, Betts R, Pourkomailian B, Zwietering MH.
PMID: 28350184
J Food Prot. 2017 Mar 28;725-733. doi: 10.4315/0362-028X.JFP-16-237. Epub 2017 Mar 28.

Over the last 10 years, some high-profile foodborne illness outbreaks have been linked to the consumption of leafy greens. Growers are required to complete microbiological risk assessments (RAs) for the production of leafy crops supplied either to retail or...

Cite
Monaghan JM, Augustin JC, Bassett J, et al. Risk Assessment or Assessment of Risk? Developing an Evidence-Based Approach for Primary Producers of Leafy Vegetables To Assess and Manage Microbial Risks. J Food Prot. 2017;725-733doi: 10.4315/0362-028X.JFP-16-237.
Monaghan, J. M., Augustin, J. C., Bassett, J., Betts, R., Pourkomailian, B., & Zwietering, M. H. (2017). Risk Assessment or Assessment of Risk? Developing an Evidence-Based Approach for Primary Producers of Leafy Vegetables To Assess and Manage Microbial Risks. Journal of food protection, 725-733. https://doi.org/10.4315/0362-028X.JFP-16-237
Monaghan, J M, et al. "Risk Assessment or Assessment of Risk? Developing an Evidence-Based Approach for Primary Producers of Leafy Vegetables To Assess and Manage Microbial Risks." Journal of food protection vol. (2017): 725-733. doi: https://doi.org/10.4315/0362-028X.JFP-16-237
Monaghan JM, Augustin JC, Bassett J, Betts R, Pourkomailian B, Zwietering MH. Risk Assessment or Assessment of Risk? Developing an Evidence-Based Approach for Primary Producers of Leafy Vegetables To Assess and Manage Microbial Risks. J Food Prot. 2017 Mar 28;725-733. doi: 10.4315/0362-028X.JFP-16-237. Epub 2017 Mar 28. PMID: 28350184.
Copy Download .nbib Format: NLM
Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

MacDonald KPA, Betts BC, Couriel D.
PMID: 29425517
Biol Blood Marrow Transplant. 2018 Mar;24(3):S7-S14. doi: 10.1016/j.bbmt.2017.12.788.

No abstract available.

Cite
MacDonald KPA, Betts BC, Couriel D. Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018;24(3):S7-S14doi: 10.1016/j.bbmt.2017.12.788.
MacDonald, K. P. A., Betts, B. C., & Couriel, D. (2018). Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 24(3), S7-S14. https://doi.org/10.1016/j.bbmt.2017.12.788
MacDonald, Kelli P A, et al. "Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 24,3 (2018): S7-S14. doi: https://doi.org/10.1016/j.bbmt.2017.12.788
MacDonald KPA, Betts BC, Couriel D. Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018 Mar;24(3):S7-S14. doi: 10.1016/j.bbmt.2017.12.788. PMID: 29425517.
Copy Download .nbib Format: NLM
Availability, quality and price of produce in low-income neighbourhood food stores in California raise equity issues - CORRIGENDUM.

Public health nutrition

Gosliner W, Brown DM, Sun BC, Woodward-Lopez G, Crawford PB.
PMID: 30378524
Public Health Nutr. 2019 Jan;22(1):184-185. doi: 10.1017/S1368980018002823. Epub 2018 Oct 31.

No abstract available.

Cite
Gosliner W, Brown DM, Sun BC, et al. Availability, quality and price of produce in low-income neighbourhood food stores in California raise equity issues - CORRIGENDUM. Public Health Nutr. 2018;22(1):184-185doi: 10.1017/S1368980018002823.
Gosliner, W., Brown, D. M., Sun, B. C., Woodward-Lopez, G., & Crawford, P. B. (2019). Availability, quality and price of produce in low-income neighbourhood food stores in California raise equity issues - CORRIGENDUM. Public health nutrition, 22(1), 184-185. https://doi.org/10.1017/S1368980018002823
Gosliner, Wendi, et al. "Availability, quality and price of produce in low-income neighbourhood food stores in California raise equity issues - CORRIGENDUM." Public health nutrition vol. 22,1 (2019): 184-185. doi: https://doi.org/10.1017/S1368980018002823
Gosliner W, Brown DM, Sun BC, Woodward-Lopez G, Crawford PB. Availability, quality and price of produce in low-income neighbourhood food stores in California raise equity issues - CORRIGENDUM. Public Health Nutr. 2019 Jan;22(1):184-185. doi: 10.1017/S1368980018002823. Epub 2018 Oct 31. PMID: 30378524; PMCID: PMC8054329.
Copy Download .nbib Format: NLM
Improving the accuracy of .

Magnetic resonance in chemistry : MRC

Dewis L, Crouch R, Russell D, Butts C.
PMID: 31237710
Magn Reson Chem. 2019 Dec;57(12):1143-1149. doi: 10.1002/mrc.4904. Epub 2019 Jul 29.

With the rise in fluorinated pharmaceuticals, it is becoming increasingly important to develop new

Cite
Dewis L, Crouch R, Russell D, et al. Improving the accuracy of . Magn Reson Chem. 2019;57(12):1143-1149doi: 10.1002/mrc.4904.
Dewis, L., Crouch, R., Russell, D., & Butts, C. (2019). Improving the accuracy of . Magnetic resonance in chemistry : MRC, 57(12), 1143-1149. https://doi.org/10.1002/mrc.4904
Dewis, Lydia, et al. "Improving the accuracy of ." Magnetic resonance in chemistry : MRC vol. 57,12 (2019): 1143-1149. doi: https://doi.org/10.1002/mrc.4904
Dewis L, Crouch R, Russell D, Butts C. Improving the accuracy of . Magn Reson Chem. 2019 Dec;57(12):1143-1149. doi: 10.1002/mrc.4904. Epub 2019 Jul 29. PMID: 31237710.
Copy Download .nbib Format: NLM
The Future of Origin of Life Research: Bridging Decades-Old Divisions.

Life (Basel, Switzerland)

Preiner M, Asche S, Becker S, Betts HC, Boniface A, Camprubi E, Chandru K, Erastova V, Garg SG, Khawaja N, Kostyrka G, Machné R, Moggioli G, Muchowska KB, Neukirchen S, Peter B, Pichlhöfer E, Radványi Á, Rossetto D, Salditt A, Schmelling NM, Sousa FL, Tria FDK, Vörös D, Xavier JC.
PMID: 32110893
Life (Basel). 2020 Feb 26;10(3). doi: 10.3390/life10030020.

Research on the origin of life is highly heterogeneous. After a peculiar historical development, it still includes strongly opposed views which potentially hinder progress. In the 1st Interdisciplinary Origin of Life Meeting, early-career researchers gathered to explore the commonalities...

Cite
Preiner M, Asche S, Becker S, et al. The Future of Origin of Life Research: Bridging Decades-Old Divisions. Life (Basel). 2020;10(3)doi: 10.3390/life10030020.
Preiner, M., Asche, S., Becker, S., Betts, H. C., Boniface, A., Camprubi, E., Chandru, K., Erastova, V., Garg, S. G., Khawaja, N., Kostyrka, G., Machné, R., Moggioli, G., Muchowska, K. B., Neukirchen, S., Peter, B., Pichlhöfer, E., Radványi, �. �., Rossetto, D., Salditt, A., Schmelling, N. M., Sousa, F. L., Tria, F. D. K., Vörös, D., & Xavier, J. C. (2020). The Future of Origin of Life Research: Bridging Decades-Old Divisions. Life (Basel, Switzerland), 10(3), . https://doi.org/10.3390/life10030020
Preiner, Martina, et al. "The Future of Origin of Life Research: Bridging Decades-Old Divisions." Life (Basel, Switzerland) vol. 10,3 (2020). doi: https://doi.org/10.3390/life10030020
Preiner M, Asche S, Becker S, Betts HC, Boniface A, Camprubi E, Chandru K, Erastova V, Garg SG, Khawaja N, Kostyrka G, Machné R, Moggioli G, Muchowska KB, Neukirchen S, Peter B, Pichlhöfer E, Radványi Á, Rossetto D, Salditt A, Schmelling NM, Sousa FL, Tria FDK, Vörös D, Xavier JC. The Future of Origin of Life Research: Bridging Decades-Old Divisions. Life (Basel). 2020 Feb 26;10(3). doi: 10.3390/life10030020. PMID: 32110893; PMCID: PMC7151616.
Copy Download .nbib Format: NLM
Improving the quality of handover: implementing SBAR.

Future healthcare journal

Ruhomauly Z, Betts K, Jayne-Coupe K, Karanfilian L, Szekely M, Relwani A, McCay J, Jaffry Z.
PMID: 31572947
Future Healthc J. 2019 Jun;6:54. doi: 10.7861/futurehosp.6-2s-s54.

No abstract available.

Cite
Ruhomauly Z, Betts K, Jayne-Coupe K, et al. Improving the quality of handover: implementing SBAR. Future Healthc J. 2019;6:54doi: 10.7861/futurehosp.6-2s-s54.
Ruhomauly, Z., Betts, K., Jayne-Coupe, K., Karanfilian, L., Szekely, M., Relwani, A., McCay, J., & Jaffry, Z. (2019). Improving the quality of handover: implementing SBAR. Future healthcare journal, 654. https://doi.org/10.7861/futurehosp.6-2s-s54
Ruhomauly, Zeinab, et al. "Improving the quality of handover: implementing SBAR." Future healthcare journal vol. 6 (2019): 54. doi: https://doi.org/10.7861/futurehosp.6-2s-s54
Ruhomauly Z, Betts K, Jayne-Coupe K, Karanfilian L, Szekely M, Relwani A, McCay J, Jaffry Z. Improving the quality of handover: implementing SBAR. Future Healthc J. 2019 Jun;6:54. doi: 10.7861/futurehosp.6-2s-s54. PMID: 31572947; PMCID: PMC6752450.
Copy Download .nbib Format: NLM
Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.

Clinical cancer research : an official journal of the American Association for Cancer Research

Taylor MH, Betts CB, Maloney L, Nadler E, Algazi A, Guarino MJ, Nemunaitis J, Jimeno A, Patel P, Munugalavadla V, Tao L, Adkins D, Goldschmidt JH, Cohen EEW, Coussens LM.
PMID: 34862248
Clin Cancer Res. 2021 Dec 03; doi: 10.1158/1078-0432.CCR-21-2547. Epub 2021 Dec 03.

PURPOSE: Programmed cell death-1 (PD-1) receptor inhibitors have shown efficacy in head and neck squamous cell carcinoma (HNSCC), but treatment failure or secondary resistance occurs in most patients. In preclinical murine carcinoma models, inhibition of Bruton's tyrosine kinase (BTK)...

Cite
Taylor MH, Betts CB, Maloney L, et al. Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-2547.
Taylor, M. H., Betts, C. B., Maloney, L., Nadler, E., Algazi, A., Guarino, M. J., Nemunaitis, J., Jimeno, A., Patel, P., Munugalavadla, V., Tao, L., Adkins, D., Goldschmidt, J. H., Cohen, E. E. W., & Coussens, L. M. (2021). Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-2547
Taylor, Matthew H, et al. "Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-2547
Taylor MH, Betts CB, Maloney L, Nadler E, Algazi A, Guarino MJ, Nemunaitis J, Jimeno A, Patel P, Munugalavadla V, Tao L, Adkins D, Goldschmidt JH, Cohen EEW, Coussens LM. Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clin Cancer Res. 2021 Dec 03; doi: 10.1158/1078-0432.CCR-21-2547. Epub 2021 Dec 03. PMID: 34862248.
Copy Download .nbib Format: NLM
MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging.

Nature methods

Schapiro D, Sokolov A, Yapp C, Chen YA, Muhlich JL, Hess J, Creason AL, Nirmal AJ, Baker GJ, Nariya MK, Lin JR, Maliga Z, Jacobson CA, Hodgman MW, Ruokonen J, Farhi SL, Abbondanza D, McKinley ET, Persson D, Betts C, Sivagnanam S, Regev A, Goecks J, Coffey RJ, Coussens LM, Santagata S, Sorger PK.
PMID: 34824477
Nat Methods. 2021 Nov 25; doi: 10.1038/s41592-021-01308-y. Epub 2021 Nov 25.

Highly multiplexed tissue imaging makes detailed molecular analysis of single cells possible in a preserved spatial context. However, reproducible analysis of large multichannel images poses a substantial computational challenge. Here, we describe a modular and open-source computational pipeline, MCMICRO,...

Cite
Schapiro D, Sokolov A, Yapp C, et al. MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging. Nat Methods. 2021;doi: 10.1038/s41592-021-01308-y.
Schapiro, D., Sokolov, A., Yapp, C., Chen, Y. A., Muhlich, J. L., Hess, J., Creason, A. L., Nirmal, A. J., Baker, G. J., Nariya, M. K., Lin, J. R., Maliga, Z., Jacobson, C. A., Hodgman, M. W., Ruokonen, J., Farhi, S. L., Abbondanza, D., McKinley, E. T., Persson, D., Betts, C., Sivagnanam, S., Regev, A., Goecks, J., Coffey, R. J., Coussens, L. M., Santagata, S., & Sorger, P. K. (2021). MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging. Nature methods, . https://doi.org/10.1038/s41592-021-01308-y
Schapiro, Denis, et al. "MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging." Nature methods vol. (2021). doi: https://doi.org/10.1038/s41592-021-01308-y
Schapiro D, Sokolov A, Yapp C, Chen YA, Muhlich JL, Hess J, Creason AL, Nirmal AJ, Baker GJ, Nariya MK, Lin JR, Maliga Z, Jacobson CA, Hodgman MW, Ruokonen J, Farhi SL, Abbondanza D, McKinley ET, Persson D, Betts C, Sivagnanam S, Regev A, Goecks J, Coffey RJ, Coussens LM, Santagata S, Sorger PK. MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging. Nat Methods. 2021 Nov 25; doi: 10.1038/s41592-021-01308-y. Epub 2021 Nov 25. PMID: 34824477.
Copy Download .nbib Format: NLM
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply.

The Lancet. Rheumatology

Rentsch CT, DeVito NJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Schultze A, Hulme WJ, Croker R, Walker AJ, Williamson EJ, Bates C, Bacon S, Mehrkar A, Curtis HJ, Evans D, Wing K, Inglesby P, Mathur R, Drysdale H, Wong AYS, McDonald HI, Cockburn J, Forbes H, Parry J, Hester F, Harper S, Smeeth L, Douglas IJ, Dixon WG, Evans SJW, Tomlinson L, Goldacre B.
PMID: 33655224
Lancet Rheumatol. 2021 Mar;3(3):e172-e173. doi: 10.1016/S2665-9913(21)00030-8. Epub 2021 Jan 27.

No abstract available.

Cite
Rentsch CT, DeVito NJ, MacKenna B, et al. Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021;3(3):e172-e173doi: 10.1016/S2665-9913(21)00030-8.
Rentsch, C. T., DeVito, N. J., MacKenna, B., Morton, C. E., Bhaskaran, K., Brown, J. P., Schultze, A., Hulme, W. J., Croker, R., Walker, A. J., Williamson, E. J., Bates, C., Bacon, S., Mehrkar, A., Curtis, H. J., Evans, D., Wing, K., Inglesby, P., Mathur, R., Drysdale, H., Wong, A. Y. S., McDonald, H. I., Cockburn, J., Forbes, H., Parry, J., Hester, F., Harper, S., Smeeth, L., Douglas, I. J., Dixon, W. G., Evans, S. J. W., Tomlinson, L., & Goldacre, B. (2021). Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. The Lancet. Rheumatology, 3(3), e172-e173. https://doi.org/10.1016/S2665-9913(21)00030-8
Rentsch, Christopher T, et al. "Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply." The Lancet. Rheumatology vol. 3,3 (2021): e172-e173. doi: https://doi.org/10.1016/S2665-9913(21)00030-8
Rentsch CT, DeVito NJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Schultze A, Hulme WJ, Croker R, Walker AJ, Williamson EJ, Bates C, Bacon S, Mehrkar A, Curtis HJ, Evans D, Wing K, Inglesby P, Mathur R, Drysdale H, Wong AYS, McDonald HI, Cockburn J, Forbes H, Parry J, Hester F, Harper S, Smeeth L, Douglas IJ, Dixon WG, Evans SJW, Tomlinson L, Goldacre B. Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021 Mar;3(3):e172-e173. doi: 10.1016/S2665-9913(21)00030-8. Epub 2021 Jan 27. PMID: 33655224; PMCID: PMC7906669.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 388 entries